Exact Mass: 557.1400688

Exact Mass Matches: 557.1400688

Found 65 metabolites which its exact mass value is equals to given mass value 557.1400688, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Vantin

1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C21H27N5O9S2 (557.1250132000001)

The 1-[(isopropoxycarbonyl)oxy]ethyl (proxetil) ester prodrug of cefpodoxime. After swallowing, hydrolysis of the ester group occurs in the intestinal epithelium, to release active cefpodoxime in the bloodstream. It is used to treat acute otitis media, pharyngitis, and sinusitis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Azidopine

3-{2-[(4-azidophenyl)formamido]ethyl} 5-ethyl 2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylic acid

C27H26F3N5O5 (557.1885942)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

Rhodomycin D

C28H31NO11 (557.1897016)

An anthracycline that is aklavinone having a 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl residue attached at position 4 via a glycosidic linkage.

dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-D-glucose

dTDP-3-N,N-dimethylamino-2,3,6-trideoxy-4-keto-D-glucose; dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-D-glucose

C18H29N3O13P2 (557.1175564)

dTDP-3-N,N-dimethylamino-4-keto-2,3,6-trideoxy-L-allose

C18H29N3O13P2 (557.1175564)

6-CFDA N-succinimidyl ester

2,5-Dioxopyrrolidin-1-yl 3,6-bis(acetyloxy)-3-oxo-3H-spiro[2-benzofuran-1,9-xanthene]-6-carboxylic acid

C29H19NO11 (557.0958064)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

cefpodoxime proxetil

1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7-[2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C21H27N5O9S2 (557.1250132000001)

Guadecitabine

{[5-(4-amino-2-oxo-1,2-dihydro-1,3,5-triazin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}({[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy})phosphinic acid

C18H24N9O10P (557.1383694)

Cys Cys Phe Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C26H31N5O5S2 (557.1766516)

Cys Cys Trp Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C26H31N5O5S2 (557.1766516)

Cys Phe Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C26H31N5O5S2 (557.1766516)

Cys Phe Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

Cys Trp Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C26H31N5O5S2 (557.1766516)

Cys Trp Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

Mezlocillin penicilloate

C21H27N5O9S2 (557.1250132000001)

Phe Cys Cys Trp

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C26H31N5O5S2 (557.1766516)

Phe Cys Trp Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

Phe Trp Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

Trp Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C26H31N5O5S2 (557.1766516)

Trp Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

Trp Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C26H31N5O5S2 (557.1766516)

SGI-110

Guadecitabine

C18H24N9O10P (557.1383694)

C471 - Enzyme Inhibitor > C2083 - DNA Methyltransferase Inhibitor C274 - Antineoplastic Agent > C132686 - Demethylating Agent D000970 - Antineoplastic Agents

5-(((2,5-DIOXOPYRROLIDIN-1-YL)OXY)CARBONYL)-3-OXO-3H-SPIRO[ISOBENZOFURAN-1,9-XANTHENE]-3,6-DIYL DIACETATE

C29H19NO11 (557.0958064)

5-Carboxyfluorescein diacetate N-succinimidyl ester

C29H19NO11 (557.0958064)

Canertinib dihydrochloride

C24H27Cl3FN5O3 (557.1163414)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents D000970 - Antineoplastic Agents D002317 - Cardiovascular Agents

1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate

C21H27N5O9S2 (557.1250132000001)

alpha-beta Methylene ADP-ribose

C16H25N5O13P2 (557.092406)

Pixantrone maleate

Pixantrone dimaleate

C25H27N5O10 (557.1757842000001)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

(2R,4S)-4-[(2R,4S,5S,6S)-4-azaniumyl-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate

C28H31NO11 (557.1897016)

(2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylic acid

C28H31NO11 (557.1897016)

(E)-CefpodoximeProxetil

1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C21H27N5O9S2 (557.1250132000001)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

[(2S,3R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl [5-(4-amino-2-oxo-1,3,5-triazin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate

C18H24N9O10P (557.1383694)

(2-amino-2-oxoethyl)-[(E)-3-[7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium

C20H26FN8O6S2+ (557.1400688)

cefpodoxime proxetil

1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C21H27N5O9S2 (557.1250132000001)

4-[6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl]benzene-1,3-disulfonate

C27H29N2O7S2- (557.1416104)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes

(1R,2R,4S)-4-[(3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

C28H31NO11 (557.1897016)

(2-amino-2-oxoethyl)-[(E)-3-[(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium

(2-amino-2-oxoethyl)-[(E)-3-[(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium

C20H26FN8O6S2+ (557.1400688)

N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

2-fluoro-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide

C24H32FN3O7S2 (557.1665614)

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C25H33Cl2N3O5S (557.1517868000001)

FMN-L-threonine

C21H28N5O11P (557.1522868)

A L-threonine derivative that is L-threonine attached via its side-chain to FMN via a phosphate linkage.

10-Carboxy-13-deoxydaunorubicin

C28H31NO11 (557.1897016)

An anthracycline antibiotic that is 13-deoxydaunorubicin substituted at position 10 by a carboxy group.

(1R,2S,3S,4R)-6-[1-[(4-chloro-3-sulfamoylbenzoyl)amino]-5-hydroxy-2-methyl-2,3,4,5-tetrahydroindol-4-yl]-2,3,4-trihydroxycyclohexane-1-carboxylic acid

C23H28ClN3O9S (557.1234708000001)

Azidopine

C27H26F3N5O5 (557.1885942)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

10-carboxy-13-deoxydaunorubicin zwitterion

C28H31NO11 (557.1897016)

A zwitterion obtained by transfer of a proton from the carboxy to the primary amino group of 10-carboxy-13-deoxydaunorubicin; major species at pH 7.3.

DQP-1105

C29H24BrN3O4 (557.0950084)

DQP-1105 is a potent noncompetitive NMDA receptor antagonist. DQP-1105 inhibits GluN2C- and GluN2D-containing receptors (IC50=7.0 and 2.7 μM, respectively). The IC50 values are at least 50-fold lower than those for recombinant GluN2A-, GluN2B-, GluA1-, or GluK2-containing receptors[1].

2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

C30H23NO10 (557.1321898)

methyl (2r)-4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C28H31NO11 (557.1897016)

2-amino-3-(3,4,5-trihydroxyphenyl)-n-[2-(3,4,5-trihydroxyphenyl)-1-{[(1z)-2-(3,4,5-trihydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl}ethyl]propanimidic acid

C26H27N3O11 (557.1645512)

(2r,3s,4s,7s,14s)-2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

(2r,3s,4s,7s,14s)-2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid

C30H23NO10 (557.1321898)

(2z)-2-(2-imino-3h-1,3-thiazol-4-yl)-n-[(6r,7r)-2-({1-[(isopropoxycarbonyl)oxy]ethoxy}carbonyl)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(methoxyimino)ethanimidic acid

C21H27N5O9S2 (557.1250132000001)

7,19-dihydroxy-6-(2-hydroxyethyl)-11,17-dimethyl-3,9,15,21-tetraoxo-22-oxa-6-azaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),4,7,10,12(26),16,18,20(25)-octaen-24-yl acetate

7,19-dihydroxy-6-(2-hydroxyethyl)-11,17-dimethyl-3,9,15,21-tetraoxo-22-oxa-6-azaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),4,7,10,12(26),16,18,20(25)-octaen-24-yl acetate

C30H23NO10 (557.1321898)

12-(3,4-dimethoxyphenyl)-7-hydroxy-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one

C31H27NO9 (557.1685732000001)

methyl 4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C28H31NO11 (557.1897016)